Accumulating results from studies on the neuroprotective functions of leptin signaling in animal models of neurodegeneration and observations in individuals with neurodegenerative disorders support the hypothesis that leptin and leptin receptors are potential therapeutic targets in neurodegenerative diseases. This evidence concerns the gene LEPR and neurodegenerative disease.